Prostate neuroendocrine carcinoma successfully treated with etoposide and cisplatin
A patient with neuroendocrine carcinoma of the prostate was successfully treated with etoposide and cisplatin, and the patient remained in remission. Prostate neuroendocrine carcinomas are rare and have poor prognoses. Therefore, information regarding treatments that can improve prognosis is needed.
Authors
- M. Ishizaki (ORCID: https://orcid.org/0009-0006-2441-543X)
- Kazumichi Muramatsu
- Masaru Hasumi
- Nobuaki Shimizu (ORCID: https://orcid.org/0000-0002-5081-0488)
Institutions
- Hyogo Prefectural Cancer Center (JP)
Publication Details
- Journal
- IJU Case Reports
- Published
- 2024-09-22
- DOI
- https://doi.org/10.1002/iju5.12787
- Citations
- 1
- Primary Topic
- Neuroendocrine Tumor Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 0.39